LIPIL line complete
This article was originally published in The Tan Sheet
Executive Summary
Enfacare LIPIL, intended for premature babies after they leave the hospital, rounds out Mead Johnson's ARA-, DHA-fortified infant formula line, BMS subsidiary announces Aug. 20. Line extension contains same levels of docosahexaenoic acid, arachidonic acid as Enfamil LIPIL preterm, term formulas, but differs in fat levels. Enfacare, which will reach shelves in late summer/early fall, is line-priced with other two LIPIL products and will retail for about 10%-15% more than original Enfacare formulas. Firm also plans to give free cases of Enfamil LIPIL with Iron to mothers who give birth on Labor Day...
You may also be interested in...
Similac Advance preterm extension
Abbott Labs division Ross Products to launch three preterm formulas: NeoSure Advance, Similac Special Care and Similac Natural Care. Infant formulas are fortified with docosahexaenoic and arachidonic acids, complement firm's DHA- and ARA-fortified Similac Advance for term infants. New formulas, hitting shelves this month, will compete with Mead Johnson's recently completed Enfamil LIPIL line; BMS division launched enriched Enfacare in August (1"The Tan Sheet" Aug. 26, 2002, In Brief)...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.